Meloxicam

Generic name: Pronounced as (mel ox' i cam)
Brand names
  • Mobic®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2021

People who take nonsteroidal anti-inflammatory drugs (NSAIDs) (other than aspirin) such as meloxicam may have a higher risk of having a heart attack, or a stroke than people who do not take these medications. These events may happen without warning and may cause death. This risk may be higher for people who take NSAIDs for a long time. Do not take an NSAID such as meloxicam if you have recently had a heart attack, unless directed to do so by your doctor. Tell your doctor if you or anyone in your family has or has ever had heart disease, a heart attack, a stroke, if you smoke, and if you have or have ever had high cholesterol, high blood pressure, or diabetes. Get emergency medical help right away if you experience any of the following symptoms: chest pain, shortness of breath, weakness in one part or side of the body, or slurred speech.

If you will be undergoing a coronary artery bypass graft (CABG; a type of heart surgery), you should not take meloxicam right before or right after the surgery.

NSAIDs such as meloxicam may cause ulcers, bleeding, or holes in the stomach or intestine. These problems may develop at any time during treatment, may happen without warning symptoms, and may cause death. The risk may be higher for people who take NSAIDs for a long time, are older in age, have poor health, or drink large amounts of alcohol while taking meloxicam. Tell your doctor if you take any of the following medications: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin; other NSAIDs such as ibuprofen (Advil, Motrin) or naproxen (Aleve, Naprosyn); oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos); selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), fluoxetine (Prozac, Sarafem, Selfemra, in Symbyax), fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); or serotonin norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine (Khedezla, Pristiq), duloxetine (Cymbalta), and venlafaxine (Effexor XR). Also tell your doctor if you have or have ever had ulcers or bleeding in your stomach or intestines, or other bleeding disorders. If you experience any of the following symptoms, stop taking meloxicam and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Keep all appointments with your doctor and the laboratory. Your doctor will monitor your symptoms carefully and will probably order certain tests to check your body's response to meloxicam. Be sure to tell your doctor how you are feeling so that your doctor can prescribe the right amount of medication to treat your condition with the lowest risk of serious side effects.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with meloxicam and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

Meloxicam is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Meloxicam is also used to relieve the pain, tenderness, swelling, and stiffness caused by juvenile rheumatoid arthritis (a type of arthritis that affects children) in children 2 years of age and older. Meloxicam is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Meloxicam comes as a tablet and suspension (liquid) to take by mouth. It is usually taken once a day with or without food. Take meloxicam at the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take meloxicam exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Shake the suspension well before each use to mix the medication evenly.

Meloxicam is also used sometimes to treat ankylosing spondylitis (arthritis that mainly affects the spine). Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking meloxicam,

  • tell your doctor and pharmacist if you are allergic to meloxicam, sorbitol, aspirin or other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn),any other medications, or any of the ingredients in meloxicam tablets and suspension. Ask your doctor or pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril , enalapril (Vasotec, in Vaseretic), fosinopril, lisinopril (in Zestoretic), and quinapril (Accupril, in Accuretic, in Quinaretic); angiotensin receptor blockers such as azilsartan (Edarbi, in Edarbyclor), candesartan (Atacand, in Atacand HCT), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar, in Hyzaar), olmesartan (Benicar, in Azor, in Benicar HCT, in Tribenzor), telmisartan (Micardis, in Micardis HCT, in Twynsta); beta blockers such as atenolol (Tenormin, in Tenoretic), labetalol (Trandate), metoprolol (Lopressor, Toprol XL, in Dutoprol), nadolol (Corgard, in Corzide), and propranolol (Hemangeol, Inderal, Innopran); cholestyramine (Prevalite); cyclosporine (Gengraf, Neoral, Sandimmune); diuretics ('water pills'); lithium (Lithobid); methotrexate (Otrexup, Rasuvo, Trexall); and pemetrexed (Alimta). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma, especially if you have frequent stuffed or runny nose or nasal polyps (swelling of the lining of the nose); heart failure; swelling of the hands, feet, ankles, or lower legs; or kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant; or are breast-feeding. Meloxicam may harm the fetus and cause problems with delivery if it is taken around 20 weeks or later during pregnancy. Do not take meloxicam around or after 20 weeks of pregnancy, unless you are told to do so by your doctor. If you become pregnant while taking meloxicam, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking meloxicam.

  • if you have fructose intolerance (an inherited condition in which the body lacks the protein needed to break down fructose [a fruit sugar found in certain sweeteners such as sorbitol]), you should know that the oral suspension is sweetened with sorbitol. Tell your doctor if you have fructose intolerance.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Meloxicam may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • diarrhea

    • constipation

    • gas

    • sore throat

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately. Do not take any more meloxicam until you speak to your doctor:

    • fever

    • blisters

    • rash

    • skin blisters or peeling

    • hives

    • itching

    • swelling of the eyes, face, tongue, lips, or throat

    • difficulty breathing or swallowing

    • hoarseness

    • pale skin

    • fast heartbeat

    • shortness of breath or difficulty breathing

    • unexplained weight gain,

    • swelling in the abdomen, ankles, feet, or legs

    • nausea

    • excessive tiredness

    • lack of energy

    • yellowing of the skin or eyes

    • pain in the right upper part of the stomach

    • flu-like symptoms

    • cloudy, discolored, or bloody urine

    • back pain

    • difficult or painful urination

  • Meloxicam may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • lack of energy

  • drowsiness

  • nausea

  • vomiting

  • stomach pain

  • bloody, black, or tarry stools

  • vomit that is bloody or looks like coffee grounds

  • difficulty breathing

  • seizures

  • coma

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin Meloxicam may increase the neuroexcitatory activities of Moxifloxacin.
Montelukast Montelukast The metabolism of Meloxicam can be decreased when combined with Montelukast.
Leflunomide Leflunomide The metabolism of Meloxicam can be decreased when combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Meloxicam can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Meloxicam can be decreased when combined with Nevirapine.
Alendronate Alendronate The risk or severity of adverse effects can be increased when Meloxicam is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Meloxicam is combined with Anagrelide.
Candesartan Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Meloxicam.
Cilostazol Cilostazol The risk or severity of bleeding can be increased when Meloxicam is combined with Cilostazol.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Meloxicam is combined with Clopidogrel.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Meloxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate Meloxicam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Meloxicam.
Magnesium Hydroxide Magnesium Hydroxide Meloxicam may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Meloxicam.
Mycophenolate Mycophenolate Meloxicam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of hypertension can be increased when Meloxicam is combined with Naratriptan.
Olsalazine Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Meloxicam.
Penbutolol Penbutolol Meloxicam may decrease the antihypertensive activities of Acebutolol.
Potassium Potassium The therapeutic efficacy of Meloxicam can be decreased when used in combination with Potassium.
Prednisone Prednisone The risk or severity of gastrointestinal irritation can be increased when Meloxicam is combined with Prednisone.
Ranitidine Ranitidine Meloxicam may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The therapeutic efficacy of Reserpine can be decreased when used in combination with Meloxicam.
Rizatriptan Rizatriptan Meloxicam may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Meloxicam may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of renal failure can be increased when Meloxicam is combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Etidronic acid.
Triamcinolone Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Meloxicam.
Zolmitriptan Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Meloxicam.
Ampicillin Injection Ampicillin Injection Meloxicam may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Meloxicam may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The metabolism of Meloxicam can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Meloxicam may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Meloxicam may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Meloxicam may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Meloxicam.
Metoclopramide Injection Metoclopramide Injection Meloxicam may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Metronidazole Injection Metronidazole Injection The metabolism of Meloxicam can be decreased when combined with Metronidazole.
Pamidronate Injection Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Meloxicam may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Meloxicam.
Altretamine Altretamine Meloxicam may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefuroxime.
Cyclosporine Cyclosporine The risk or severity of renal failure and hypertension can be increased when Meloxicam is combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Meloxicam.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Enoxaparin.
Torsemide Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Meloxicam.
Olanzapine Olanzapine The metabolism of Meloxicam can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Meloxicam.
Eprosartan Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Meloxicam.
Pantoprazole Pantoprazole Meloxicam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Meloxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Meloxicam.
Temozolomide Temozolomide Meloxicam may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Meloxicam may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Meloxicam can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Meloxicam.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Meloxicam can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Meloxicam can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Meloxicam can be decreased when combined with Modafinil.
Perindopril Perindopril The therapeutic efficacy of Perindopril can be decreased when used in combination with Meloxicam.
Tenofovir Tenofovir Meloxicam may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of adverse effects can be increased when Meloxicam is combined with Choline magnesium trisalicylate.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Meloxicam is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Meloxicam can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The therapeutic efficacy of Eplerenone can be decreased when used in combination with Meloxicam.
Escitalopram Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Meloxicam.
Olmesartan Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Meloxicam.
Zonisamide Zonisamide The therapeutic efficacy of Zonisamide can be decreased when used in combination with Meloxicam.
Adalimumab Injection Adalimumab Injection The metabolism of Meloxicam can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypertension can be increased when Meloxicam is combined with Aripiprazole.
Atomoxetine Atomoxetine Meloxicam may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate The risk or severity of hypertension can be increased when Meloxicam is combined with Dexmethylphenidate.
Atazanavir Atazanavir The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Atazanavir.
Almotriptan Almotriptan Meloxicam may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Meloxicam can be decreased when combined with Eletriptan.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Meloxicam.
Aprepitant Aprepitant The metabolism of Meloxicam can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Meloxicam may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Meloxicam may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil The therapeutic efficacy of Tadalafil can be decreased when used in combination with Meloxicam.
Frovatriptan Frovatriptan The risk or severity of hypertension can be increased when Meloxicam is combined with Frovatriptan.
Gemifloxacin Gemifloxacin Meloxicam may increase the neuroexcitatory activities of Gemifloxacin.
Progesterone Progesterone The metabolism of Meloxicam can be decreased when combined with Progesterone.
Infliximab Injection Infliximab Injection The metabolism of Meloxicam can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Meloxicam can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Meloxicam.
Duloxetine Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Meloxicam.
Tinidazole Tinidazole Meloxicam may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Meloxicam.
Cefditoren Cefditoren Meloxicam may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Meloxicam may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Eszopiclone Eszopiclone Meloxicam may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Meloxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Meloxicam may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of hypertension can be increased when Meloxicam is combined with Solifenacin.
Valganciclovir Valganciclovir Meloxicam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Meloxicam can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Adefovir.
Dextroamphetamine Dextroamphetamine Meloxicam may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Meloxicam can be increased when combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of hypertension can be increased when Meloxicam is combined with Isocarboxazid.
Ramelteon Ramelteon Meloxicam may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Pregabalin Pregabalin Meloxicam may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Meloxicam is combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Meloxicam.
Felbamate Felbamate The metabolism of Meloxicam can be decreased when combined with Felbamate.
Ranolazine Ranolazine Meloxicam may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Meloxicam can be increased when combined with Abatacept.
Rasagiline Rasagiline Meloxicam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The metabolism of Meloxicam can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Meloxicam may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Meloxicam may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Meloxicam can be decreased when combined with Gefitinib.
Albuterol Albuterol Meloxicam may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Meloxicam may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Bortezomib Bortezomib The metabolism of Meloxicam can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Meloxicam may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Lubiprostone Lubiprostone Meloxicam may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Aliskiren Aliskiren The risk or severity of renal failure and hypertension can be increased when Meloxicam is combined with Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meloxicam.
Pemetrexed Injection Pemetrexed Injection Meloxicam may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Lisdexamfetamine Lisdexamfetamine The risk or severity of hypertension can be increased when Meloxicam is combined with Lisdexamfetamine.
Nabilone Nabilone The metabolism of Meloxicam can be decreased when combined with Nabilone.
Sorafenib Sorafenib The metabolism of Meloxicam can be decreased when combined with Sorafenib.
Dronabinol Dronabinol The metabolism of Meloxicam can be decreased when combined with Dronabinol.
Levocetirizine Levocetirizine Meloxicam may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Meloxicam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Armodafinil Armodafinil The metabolism of Meloxicam can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Meloxicam may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Lenalidomide Lenalidomide Meloxicam may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Meloxicam can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Meloxicam can be decreased when combined with Bexarotene.
Budesonide Budesonide The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Meloxicam.
Desmopressin Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meloxicam is combined with Desmopressin.
Doripenem Injection Doripenem Injection Meloxicam may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Meloxicam can be decreased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Meloxicam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Meloxicam.
Cevimeline Cevimeline Meloxicam may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol Meloxicam may decrease the antihypertensive activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Meloxicam can be decreased when combined with Tretinoin.
Flecainide Flecainide The metabolism of Meloxicam can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Meloxicam can be increased when combined with Certolizumab pegol.
Daptomycin Injection Daptomycin Injection Meloxicam may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Meloxicam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Meloxicam may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Meloxicam may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Milnacipran Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Meloxicam.
Plerixafor Injection Plerixafor Injection Meloxicam may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Meloxicam.
Fesoterodine Fesoterodine Meloxicam may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol Meloxicam may decrease the antihypertensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of hypertension can be increased when Meloxicam is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Meloxicam.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Meloxicam.
Dronedarone Dronedarone The risk or severity of hypertension can be increased when Meloxicam is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Meloxicam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Meloxicam may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Meloxicam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Meloxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Meloxicam.
Topotecan Topotecan Meloxicam may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Meloxicam can be increased when combined with Golimumab.
Asenapine Asenapine The risk or severity of hypertension can be increased when Meloxicam is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Meloxicam.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Dabigatran.
Tocilizumab Injection Tocilizumab Injection The metabolism of Meloxicam can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Meloxicam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Ceftaroline fosamil.
Lurasidone Lurasidone The risk or severity of hypertension can be increased when Meloxicam is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Meloxicam.
Vilazodone Vilazodone The risk or severity of hypertension can be increased when Meloxicam is combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Meloxicam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Meloxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Meloxicam may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Meloxicam.
Roflumilast Roflumilast Meloxicam may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Meloxicam.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Meloxicam can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Meloxicam can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Ticagrelor.
Ruxolitinib Ruxolitinib Meloxicam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Meloxicam may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The metabolism of Meloxicam can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Meloxicam can be decreased when combined with Vismodegib.
Deferiprone Deferiprone Meloxicam may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Cabergoline Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Meloxicam.
Naloxone Injection Naloxone Injection Meloxicam may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Meloxicam.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Fondaparinux.
Iloprost Iloprost The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Meloxicam can be increased when combined with Enzalutamide.
Mirabegron Mirabegron Meloxicam may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Meloxicam can be decreased when combined with Regorafenib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Meloxicam.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Meloxicam.
Teduglutide Injection Teduglutide Injection Meloxicam may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Meloxicam is combined with Icosapent ethyl.
Alogliptin Alogliptin Meloxicam may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide Meloxicam may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Apixaban.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Meloxicam.
Methazolamide Methazolamide The therapeutic efficacy of Methazolamide can be decreased when used in combination with Meloxicam.
Dabrafenib Dabrafenib The metabolism of Meloxicam can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Meloxicam.
Trametinib Trametinib Meloxicam may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Meloxicam.
Ertapenem Injection Ertapenem Injection Meloxicam may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Meloxicam may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Meloxicam.
Sofosbuvir Sofosbuvir Meloxicam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Meloxicam.
Apremilast Apremilast The metabolism of Meloxicam can be increased when combined with Apremilast.
Droxidopa Droxidopa Meloxicam may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Meloxicam can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Meloxicam can be increased when combined with Siltuximab.
Testosterone Injection Testosterone Injection Meloxicam may decrease the excretion rate of Testosterone which could result in a higher serum level.
Oritavancin Injection Oritavancin Injection The metabolism of Meloxicam can be decreased when combined with Oritavancin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Vorapaxar.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Edoxaban.
Methamphetamine Methamphetamine Meloxicam may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Meloxicam may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat The therapeutic efficacy of Riociguat can be decreased when used in combination with Meloxicam.
Secukinumab Injection Secukinumab Injection The metabolism of Meloxicam can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of hypertension can be increased when Risperidone is combined with Meloxicam.
Lenvatinib Lenvatinib The metabolism of Meloxicam can be decreased when combined with Lenvatinib.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Meloxicam.
Amiloride Amiloride The therapeutic efficacy of Amiloride can be decreased when used in combination with Meloxicam.
Macitentan Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Meloxicam.
Flibanserin Flibanserin The risk or severity of hypertension can be increased when Meloxicam is combined with Flibanserin.
Prednisolone Prednisolone The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Meloxicam.
Brexpiprazole Brexpiprazole The risk or severity of hypertension can be increased when Meloxicam is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Meloxicam.
Cariprazine Cariprazine The risk or severity of hypertension can be increased when Meloxicam is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Meloxicam may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Meloxicam.
Ixazomib Ixazomib Meloxicam may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Meloxicam may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Meloxicam.
Dexamethasone Injection Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Meloxicam.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection Meloxicam may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Midodrine Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Meloxicam.
Selexipag Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Meloxicam.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Meloxicam.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Meloxicam.
Rucaparib Rucaparib The metabolism of Meloxicam can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Meloxicam may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Meloxicam may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Meloxicam may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Meloxicam may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of gastrointestinal irritation can be increased when Deflazacort is combined with Meloxicam.
Safinamide Safinamide The metabolism of Meloxicam can be decreased when combined with Safinamide.
Naldemedine Naldemedine Meloxicam may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Meloxicam can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Meloxicam can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Meloxicam may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Meloxicam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Meloxicam.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Meloxicam.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Meloxicam.
Apalutamide Apalutamide Apalutamide may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Avatrombopag Avatrombopag The metabolism of Meloxicam can be increased when combined with Avatrombopag.
Baricitinib Baricitinib Meloxicam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Meloxicam.
Plazomicin Injection Plazomicin Injection Meloxicam may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Meloxicam.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Meloxicam.
Stiripentol Stiripentol The metabolism of Meloxicam can be decreased when combined with Stiripentol.
Rifamycin Rifamycin The metabolism of Meloxicam can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Meloxicam may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Meloxicam can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Meloxicam.
Acyclovir Ophthalmic Acyclovir Ophthalmic Meloxicam may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Meloxicam is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Meloxicam.
Alpelisib Alpelisib The serum concentration of Meloxicam can be decreased when it is combined with Alpelisib.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Meloxicam.
Triclabendazole Triclabendazole The metabolism of Meloxicam can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Meloxicam.
Pitolisant Pitolisant The risk or severity of adverse effects can be increased when Meloxicam is combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The serum concentration of Meloxicam can be increased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Meloxicam.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Meloxicam.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Meloxicam.
Cenobamate Cenobamate The serum concentration of Meloxicam can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Meloxicam.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Meloxicam.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Meloxicam is combined with Selpercatinib.
Pralsetinib Pralsetinib The metabolism of Meloxicam can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Meloxicam can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Meloxicam is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Drospirenone.
Viloxazine Viloxazine Meloxicam may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Meloxicam may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Fenoprofen Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Meloxicam.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Meloxicam.
Mefenamic Acid Mefenamic Acid The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Meloxicam.
Naproxen Naproxen The risk or severity of adverse effects can be increased when Naproxen is combined with Meloxicam.
Tolmetin Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Meloxicam.
Sulindac Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Meloxicam.
Trazodone Trazodone The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Meloxicam.
Isotretinoin Isotretinoin Meloxicam may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Meloxicam may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine The metabolism of Meloxicam can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Meloxicam.
Metaxalone Metaxalone Meloxicam may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Primidone Primidone The metabolism of Meloxicam can be decreased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of hypertension can be increased when Meloxicam is combined with Diethylpropion.
Chlorpromazine Chlorpromazine Meloxicam may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Meloxicam may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Meloxicam may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Meloxicam may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Meloxicam may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Meloxicam may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Meloxicam.
Carmustine Carmustine Meloxicam may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Meloxicam may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Meloxicam may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hypertension can be increased when Meloxicam is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Meloxicam is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Meloxicam can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Meloxicam may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of hypertension can be increased when Meloxicam is combined with Ergoloid mesylate.
Tetracycline Tetracycline Meloxicam may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Thioridazine Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Meloxicam.
Trifluoperazine Trifluoperazine The risk or severity of hypertension can be increased when Meloxicam is combined with Trifluoperazine.
Bleomycin Bleomycin Meloxicam may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Meloxicam can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Meloxicam may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone Meloxicam may decrease the excretion rate of Methadone which could result in a higher serum level.
Benztropine Benztropine Meloxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Meloxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline Meloxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of adverse effects can be increased when Meloxicam is combined with Ibuprofen.
Azathioprine Azathioprine Meloxicam may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Meloxicam.
Methylphenidate Methylphenidate Meloxicam may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Meloxicam.
Sulfasalazine Sulfasalazine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Meloxicam.
Hydrocortisone Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Meloxicam.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Phenazopyridine.
Carbamazepine Carbamazepine Meloxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Meloxicam.
Clonidine Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Meloxicam.
Prazosin Prazosin The therapeutic efficacy of Prazosin can be decreased when used in combination with Meloxicam.
Hydralazine Hydralazine Meloxicam may decrease the antihypertensive activities of Hydralazine.
Gentamicin Injection Gentamicin Injection Meloxicam may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The risk or severity of bleeding can be increased when Meloxicam is combined with Warfarin.
Clonazepam Clonazepam Meloxicam may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Loperamide.
Promethazine Promethazine Meloxicam may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate The risk or severity of adverse effects can be increased when Meloxicam is combined with Meclofenamic acid.
Nitrofurantoin Nitrofurantoin Meloxicam may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Chloroquine Chloroquine Meloxicam may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The metabolism of Meloxicam can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Meloxicam.
Triamterene Triamterene The therapeutic efficacy of Triamterene can be decreased when used in combination with Meloxicam.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Meloxicam is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Meloxicam.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Meloxicam.
Metolazone Metolazone The therapeutic efficacy of Metolazone can be decreased when used in combination with Meloxicam.
Isosorbide Isosorbide The therapeutic efficacy of Isosorbide can be decreased when used in combination with Meloxicam.
Secobarbital Secobarbital Meloxicam may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine Meloxicam may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Imipramine Imipramine Imipramine may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Quinidine Quinidine Meloxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Meloxicam may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The metabolism of Meloxicam can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Meloxicam may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Disopyramide Disopyramide Meloxicam may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The protein binding of Valproic acid can be decreased when combined with Meloxicam.
Tamoxifen Tamoxifen The metabolism of Meloxicam can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Meloxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Meloxicam may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole The metabolism of Meloxicam can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The protein binding of Chlorpropamide can be decreased when combined with Meloxicam.
Tolbutamide Tolbutamide The protein binding of Tolbutamide can be decreased when combined with Meloxicam.
Tolazamide Tolazamide The protein binding of Tolazamide can be decreased when combined with Meloxicam.
Dextromethorphan Dextromethorphan The metabolism of Meloxicam can be decreased when combined with Dextromethorphan.
Baclofen Baclofen Meloxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Meloxicam may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Meloxicam.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meloxicam.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Meloxicam may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Meloxicam may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Meloxicam may decrease the excretion rate of Folic acid which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Meloxicam may decrease the antihypertensive activities of Propranolol.
Minoxidil Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Meloxicam.
Pseudoephedrine Pseudoephedrine The risk or severity of hypertension can be increased when Meloxicam is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The risk or severity of hypertension can be increased when Nortriptyline is combined with Meloxicam.
Spironolactone Spironolactone The therapeutic efficacy of Spironolactone can be decreased when used in combination with Meloxicam.
Amphotericin B Injection Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Meloxicam.
Phytonadione Phytonadione Meloxicam may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Meloxicam may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol Meloxicam may decrease the antihypertensive activities of Nadolol.
Cholestyramine Resin Cholestyramine Resin The serum concentration of Meloxicam can be decreased when it is combined with Cholestyramine.
Allopurinol Allopurinol Meloxicam may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Meloxicam may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The metabolism of Meloxicam can be decreased when combined with Fluorouracil.
Colchicine Colchicine Meloxicam may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Meloxicam may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Meloxicam may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefazolin.
Cephalexin Cephalexin Meloxicam may decrease the excretion rate of Cephalexin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefoxitin.
Dacarbazine Dacarbazine Meloxicam may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Meloxicam.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Meloxicam.
Calcitonin Salmon Injection Calcitonin Salmon Injection Meloxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Ketoconazole Ketoconazole The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Ketoconazole.
Pyrantel Pyrantel Meloxicam may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Captopril Captopril The therapeutic efficacy of Captopril can be decreased when used in combination with Meloxicam.
Dipyridamole Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Meloxicam is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Meloxicam.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Colistimethate.
Metoprolol Metoprolol Meloxicam may decrease the antihypertensive activities of Metoprolol.
Aspirin Aspirin The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of adverse effects can be increased when Meloxicam is combined with Salsalate.
Alprazolam Alprazolam Meloxicam may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Meloxicam may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Meloxicam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Meloxicam may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Meloxicam may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Diltiazem Diltiazem The therapeutic efficacy of Meloxicam can be decreased when used in combination with Diltiazem.
Nifedipine Nifedipine Meloxicam may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Meloxicam may decrease the antihypertensive activities of Timolol.
Verapamil Verapamil Verapamil may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Atenolol Atenolol Meloxicam may decrease the antihypertensive activities of Atenolol.
Pindolol Pindolol Meloxicam may decrease the antihypertensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection Meloxicam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Meloxicam.
Piroxicam Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Meloxicam.
Bumetanide Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Meloxicam.
Glyburide Glyburide The protein binding of Glyburide can be decreased when combined with Meloxicam.
Glipizide Glipizide The protein binding of Glipizide can be decreased when combined with Meloxicam.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be decreased when used in combination with Meloxicam.
Amoxicillin Amoxicillin Meloxicam may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Meloxicam may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Meloxicam is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Meloxicam.
Ceftriaxone Injection Ceftriaxone Injection Meloxicam may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol Meloxicam may decrease the antihypertensive activities of Labetalol.
Auranofin Auranofin Meloxicam may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Meloxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Meloxicam can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Meloxicam.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Meloxicam.
Ceftazidime Injection Ceftazidime Injection Meloxicam may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of adverse effects can be increased when Meloxicam is combined with Ketoprofen.
Cefotetan Injection Cefotetan Injection Meloxicam may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Enalapril Enalapril The therapeutic efficacy of Enalapril can be decreased when used in combination with Meloxicam.
Flurbiprofen Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meloxicam.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Meloxicam.
Aztreonam Injection Aztreonam Injection Meloxicam may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Meloxicam may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Meloxicam can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin Meloxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The therapeutic efficacy of Mesalazine can be decreased when used in combination with Meloxicam.
Diclofenac Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Meloxicam.
Fluoxetine Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Meloxicam.
Nimodipine Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Meloxicam.
Clozapine Clozapine Meloxicam may decrease the excretion rate of Clozapine which could result in a higher serum level.
Estazolam Estazolam Meloxicam may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Meloxicam.
Ofloxacin Ofloxacin Meloxicam may increase the neuroexcitatory activities of Ofloxacin.
Didanosine Didanosine Meloxicam may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Meloxicam may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The therapeutic efficacy of Benazepril can be decreased when used in combination with Meloxicam.
Etodolac Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Meloxicam.
Felodipine Felodipine The metabolism of Meloxicam can be decreased when combined with Felodipine.
Fosinopril Fosinopril The therapeutic efficacy of Fosinopril can be decreased when used in combination with Meloxicam.
Nabumetone Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Meloxicam.
Quinapril Quinapril The therapeutic efficacy of Quinapril can be decreased when used in combination with Meloxicam.
Ramipril Ramipril The therapeutic efficacy of Ramipril can be decreased when used in combination with Meloxicam.
Simvastatin Simvastatin The metabolism of Meloxicam can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Meloxicam may decrease the antihypertensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Meloxicam can be decreased when combined with Teniposide.
Itraconazole Itraconazole The serum concentration of Meloxicam can be decreased when it is combined with Itraconazole.
Lisinopril Lisinopril The therapeutic efficacy of Lisinopril can be decreased when used in combination with Meloxicam.
Oxaprozin Oxaprozin The risk or severity of adverse effects can be increased when Meloxicam is combined with Oxaprozin.
Atovaquone Atovaquone The metabolism of Meloxicam can be decreased when combined with Atovaquone.
Sotalol Sotalol Meloxicam may decrease the antihypertensive activities of Sotalol.
Bisoprolol Bisoprolol Meloxicam may decrease the antihypertensive activities of Bisoprolol.
Zolpidem Zolpidem The metabolism of Meloxicam can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The therapeutic efficacy of Doxazosin can be decreased when used in combination with Meloxicam.
Terazosin Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Meloxicam.
Isradipine Isradipine The therapeutic efficacy of Isradipine can be decreased when used in combination with Meloxicam.
Omeprazole Omeprazole The metabolism of Meloxicam can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Meloxicam can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Meloxicam can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine Venlafaxine may increase the antiplatelet activities of Meloxicam.
Fluvoxamine Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Meloxicam.
Nefazodone Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Nefazodone is combined with Meloxicam.
Lamotrigine Lamotrigine Meloxicam may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Losartan Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Meloxicam.
Valacyclovir Valacyclovir Meloxicam may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
Tramadol Tramadol Meloxicam may decrease the excretion rate of Tramadol which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Meloxicam may decrease the excretion rate of Carboplatin which could result in a higher serum level.
Moexipril Moexipril The therapeutic efficacy of Moexipril can be decreased when used in combination with Meloxicam.
Lansoprazole Lansoprazole The metabolism of Meloxicam can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection Meloxicam may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The metabolism of Meloxicam can be decreased when combined with Nicardipine.
Bupropion Bupropion Meloxicam may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Meloxicam is combined with Ticlopidine.
Metformin Metformin Meloxicam may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Dalteparin.
Nisoldipine Nisoldipine The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Meloxicam.
Lamivudine Lamivudine Meloxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Meloxicam may decrease the excretion rate of Acarbose which could result in a higher serum level.
Glimepiride Glimepiride The protein binding of Glimepiride can be decreased when combined with Meloxicam.
Gemcitabine Injection Gemcitabine Injection Meloxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Meloxicam can be increased when it is combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Meloxicam may decrease the excretion rate of Cidofovir which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meloxicam may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Meloxicam may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Zafirlukast Zafirlukast The metabolism of Meloxicam can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Meloxicam may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Meloxicam.
Trandolapril Trandolapril The therapeutic efficacy of Trandolapril can be decreased when used in combination with Meloxicam.
Topiramate Topiramate Meloxicam may decrease the excretion rate of Topiramate which could result in a higher serum level.
Zileuton Zileuton The metabolism of Meloxicam can be decreased when combined with Zileuton.
Valsartan Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Meloxicam.
Pramipexole Pramipexole Meloxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Meloxicam.
Nelfinavir Nelfinavir The metabolism of Meloxicam can be decreased when combined with Nelfinavir.
Carvedilol Carvedilol Meloxicam may decrease the antihypertensive activities of Carvedilol.
Nilutamide Nilutamide Meloxicam may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Meloxicam may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Meloxicam.
Bicalutamide Bicalutamide The metabolism of Meloxicam can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Meloxicam.
Propafenone Propafenone Meloxicam may decrease the antihypertensive activities of Propafenone.
Irbesartan Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Meloxicam.
Tamsulosin Tamsulosin Meloxicam may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Finasteride Finasteride The risk or severity of hypertension can be increased when Meloxicam is combined with Finasteride.
Quetiapine Quetiapine Meloxicam may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Cefpodoxime.
Cetirizine Cetirizine Meloxicam may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Meloxicam.
Tolcapone Tolcapone Meloxicam may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Meloxicam.
Capecitabine Capecitabine The metabolism of Meloxicam can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Meloxicam can be decreased when combined with Efavirenz.
Abacavir Abacavir Meloxicam may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Meloxicam can be decreased when combined with Sildenafil.
Celecoxib Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Meloxicam.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Meloxicam which could result in a higher serum level.
Tolterodine Tolterodine Meloxicam may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The metabolism of Thalidomide can be decreased when combined with Meloxicam.
Oseltamivir Oseltamivir Meloxicam may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Meloxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Meloxicam.
Nateglinide Nateglinide Meloxicam may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole The metabolism of Meloxicam can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Meloxicam.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists